Table: Kobayashi Pharmaceutical -2025 group results

Kobayashi Pharmaceutical Co

10/02/2026 06:32

Feb 10 (Reuters)- 
          Kobayashi Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Dec 31, 2025    Dec 31, 2024   Dec 31, 2026     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          165.74          165.60         173.00                 
               (+0.1 pct)      (-4.5 pct)     (+4.4 pct)               
  Operating       14.92           24.86          12.50                 
               (-40.0 pct)     (-3.6 pct)     (-16.2 pct)              
  Recurring       17.00           26.86          13.00                 
               (-36.7 pct)     (-1.7 pct)     (-23.5 pct)              
  Net
  Net              3.66           10.07          10.00                 
               (-63.7 pct)     (-50.5 pct)   (+173.5 pct)              
  EPS           49.19 yen      135.42 yen     134.52 yen               
  Ann Div      104.00 yen      102.00 yen     106.00 yen               
  -Q2 Div       44.00 yen       43.00 yen      45.00 yen               
  -Q4 Div       60.00 yen       59.00 yen      61.00 yen               
  
  NOTE - Kobayashi Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4967.T